Type to search

Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab | Pharmtech Focus
US FDA Approves Jardiance ® (empagliflozin) to Treat Adults with Heart Failure Regardless of Left Ventricular Ejection Fraction | Pharmtech Focus
Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control® Platform | Pharmtech Focus | Pharmtech Focus